İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2023

Musculoskeletal Involvement in Pediatric Behçet’s Disease: A Single Center Experience

Dergi

Türkiye Çocuk Hastalıkları Dergisi

ISSN 1307-4490

YÖKSİS OpenAlex Açık erişim · diamond TR Index Atıf 0 Yüzdelik 13.1% FWCI 0.0
Yıl
2023
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • YÖKSİS dergi adı Türkiye Çocuk Hastalıkları Dergisi
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

OpenAlex · İngilizce

Objective: The aim of this study was to determine the reasons for the request for antinuclear antibody (ANA) in ANA-positive patients and to determine the final diagnosis of these patients and whether they developed a rheumatologic disease. Method: In this retrospective study, the files of 559 patients with positive ANA were reviewed. Demographic, laboratory and clinical characteristics of the patients were noted. At the end of follow-up, the final diagnosis was recorded. Results: The study included 346 patients. 233 of the patients were female, and 113 were male. The mean age at the time of ANA positivity was 9.4  4.7 years, and the mean follow-up period was 19  5.7 months. The most common symptom was myalgia/arthralgia (21.7%). Other common reasons were urticaria, abdominal pain, thrombocytopenia, and proteinuria. Extractable nuclear antigens (ENA) panel results were negative in 170 patients (49.1%). In the ENA panel, dense fine speckled antigen 70 antibodies were most frequently positive in 135 patients (39.2%). At the end of follow-up, 234 patients had no disease. One hundred and one patients were diagnosed with non-rheumatologic diseases, and 11 patients were diagnosed with rheumatologic diseases. Eleven patients with rheumatologic diseases were girls. Rash was the most common symptom in patients with rheumatologic diseases. The positive predictive value of ANA positivity for rheumatologic disease was 3.2% and 1.7% for systemic lupus erythematosus. Conclusions: Due to the low positive predictive value of ANA testing, patients at risk for autoimmune diseases should be identified and carefully evaluated before ANA is requested.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

0 atıf

OpenAlex cited_by_count (önbellek / veritabanı)

Yazarlar

  1. SERKAN COŞKUN
  2. ZAHİDE EKİCİ TEKİN ANKARA YILDIRIM BEYAZIT ÜNİVERSİTESİ
  3. ELİF ÇELİKEL
  4. VİLDAN GÜNGÖRER
  5. PAKİZE NİLÜFER AKPINAR TEKGÖZ
  6. MÜGE SEZER
  7. CÜNEYT KARAGÖL
  8. MELİKE MEHVEŞ KAPLAN
  9. NİMET ÖNER
  10. MERVE CANSU POLAT
  11. BANU ÇELİKEL ACAR